[go: up one dir, main page]

ATE250066T1 - Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen - Google Patents

Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen

Info

Publication number
ATE250066T1
ATE250066T1 AT98959652T AT98959652T ATE250066T1 AT E250066 T1 ATE250066 T1 AT E250066T1 AT 98959652 T AT98959652 T AT 98959652T AT 98959652 T AT98959652 T AT 98959652T AT E250066 T1 ATE250066 T1 AT E250066T1
Authority
AT
Austria
Prior art keywords
epothilones
oxiranyl
olefinic
reducing
reduction
Prior art date
Application number
AT98959652T
Other languages
English (en)
Inventor
Soong-Hoon Kim
James A Johnson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE250066T1 publication Critical patent/ATE250066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98959652T 1997-12-04 1998-12-01 Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen ATE250066T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6754997P 1997-12-04 1997-12-04
US8256398P 1998-04-21 1998-04-21
PCT/US1998/025464 WO1999028324A1 (en) 1997-12-04 1998-12-01 A process for the reduction of oxiranyl epothilones to olefinic epothilones

Publications (1)

Publication Number Publication Date
ATE250066T1 true ATE250066T1 (de) 2003-10-15

Family

ID=26748002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959652T ATE250066T1 (de) 1997-12-04 1998-12-01 Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen

Country Status (13)

Country Link
EP (1) EP1042327B1 (de)
JP (1) JP4434484B2 (de)
KR (1) KR100574454B1 (de)
AT (1) ATE250066T1 (de)
AU (1) AU738576B2 (de)
CA (1) CA2311929A1 (de)
DE (1) DE69818304T2 (de)
ES (1) ES2207015T3 (de)
HK (1) HK1028401A1 (de)
HU (1) HUP0100582A3 (de)
IL (1) IL135590A (de)
TW (1) TWI221469B (de)
WO (1) WO1999028324A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
JP4579351B2 (ja) 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
EP1058679B1 (de) * 1998-02-25 2005-10-19 Sloan-Kettering Institute For Cancer Research Synthese von epothilonen, ihren zwischenprodukten und analogen verbindungen
IL144910A0 (en) 1999-04-15 2002-06-30 Bristol Myers Squibb Co Cyclic compounds and pharmaceutical compositions containing the same
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
JP4776843B2 (ja) 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
EP1340498A1 (de) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Verwendung von Epothilonen zur Behandlung von mit proliferativen Prozessen assoziierten Gehirnerkrankungen
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
KR20050043796A (ko) * 2002-05-20 2005-05-11 코산 바이오사이언시즈, 인코포레이티드 에포틸론 ｄ의 투여방법
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP1567487A4 (de) 2002-11-15 2005-11-16 Bristol Myers Squibb Co Offenkettige, mit prolylharnstoff verwandtemodulatoren der androgenrezeptorfunktion
EP1559447A1 (de) * 2004-01-30 2005-08-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Epothilonen zur Behandlung von neuronalen Konnektivitätsdefekten wie zum Beispiel Schizophrenie und Autismus
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
GB0405898D0 (en) 2004-03-16 2004-04-21 Novartis Ag Organic compounds
MX2010011209A (es) 2008-04-24 2010-11-12 Squibb Bristol Myers Co Uso de epotilona d en el tratamiento de enfermedades asociadas a tau incluyendo enfermedad de alzheimer.
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
AU2012207142B2 (en) 2011-01-20 2017-04-27 Board Of Regents, The University Of Texas System MRI markers, delivery and extraction systems, and methods of manufacture and use thereof
DK2717916T3 (en) 2011-06-10 2017-04-24 Mersana Therapeutics Inc PROTEIN POLYMER-drug conjugates
CN102863474A (zh) 2011-07-09 2013-01-09 陈小平 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用
CN102993239A (zh) 2011-09-19 2013-03-27 陈小平 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物
US9725477B2 (en) 2012-11-17 2017-08-08 Beijing Fswelcome Technology Development Co., Ltd Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino
WO2014093394A1 (en) 2012-12-10 2014-06-19 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
WO2014093640A1 (en) 2012-12-12 2014-06-19 Mersana Therapeutics,Inc. Hydroxy-polmer-drug-protein conjugates
EA201600003A1 (ru) 2013-06-11 2016-06-30 Байер Фарма Акциенгезельшафт КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА
EP3054991B1 (de) 2013-10-11 2019-04-03 Mersana Therapeutics, Inc. Protein-polymer-wirkstoffkonjugate
KR102572149B1 (ko) 2013-10-11 2023-08-30 아사나 바이오사이언시스 엘엘씨 단백질-폴리머-약물 접합체
CN103936748A (zh) * 2014-05-08 2014-07-23 成都摩尔生物医药有限公司 一种埃博霉素b内酰胺衍生物的制备方法
WO2018004338A1 (en) 2016-06-27 2018-01-04 Tagworks Pharmaceuticals B.V. Cleavable tetrazine used in bio-orthogonal drug activation
US11135307B2 (en) 2016-11-23 2021-10-05 Mersana Therapeutics, Inc. Peptide-containing linkers for antibody-drug conjugates
EP3641826B1 (de) 2017-06-22 2023-12-06 Mersana Therapeutics, Inc. Verfahren zur herstellung von wirkstofftragenden polymergerüsten und protein-polymer-wirkstoff-konjugaten
EP3787691A1 (de) 2018-05-04 2021-03-10 Tagworks Pharmaceuticals B.V. Tetrazine für hohe clickkonjugationsausbeute in vivo und hohe clickfreisetzungsausbeute
ES2975330T3 (es) 2018-05-04 2024-07-04 Tagworks Pharmaceuticals B V Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno
EA202191175A1 (ru) 2018-10-29 2021-09-08 Мерсана Терапьютикс, Инк. Сконструированные с цистеином конъюгаты антитело-лекарственное средство, содержащие пептидсодержащие линкеры
CA3143925A1 (en) 2019-06-17 2020-12-24 Tagworks Pharmaceuticals B.V. Compounds for fast and efficient click release
IL289094A (en) 2019-06-17 2022-02-01 Tagworks Pharmaceuticals B V Tetrazines for increasing the speed and yield of the "click release" reaction
EP4399283A2 (de) 2021-09-06 2024-07-17 Veraxa Biotech GmbH Neue aminoacyl-trna-synthetase-varianten zur genetischen codeerweiterung in eukaryoten
EP4186529A1 (de) 2021-11-25 2023-05-31 Veraxa Biotech GmbH Verbesserte antikörper-nutzlast-konjugate (aps), hergestellt durch ortsspezifische konjugation mittels genetischer codeerweiterung
KR20240105469A (ko) 2021-11-25 2024-07-05 베락사 바이오테크 게엠베하 유전자 코드 확장을 이용하는 부위-특이적 접합에 의해 제조되는 개선된 항체-페이로드 접합체 (apc)
JP2024546769A (ja) 2021-12-08 2024-12-26 ヨーロピアン モレキュラー バイオロジー ラボラトリー 標的複合体の調製のための親水性テトラジン機能化ペイロード
EP4372000A3 (de) 2022-02-15 2024-07-17 Tagworks Pharmaceuticals B.V. Maskiertes il12-protein
WO2024013724A1 (en) 2022-07-15 2024-01-18 Pheon Therapeutics Ltd Antibody-drug conjugates
WO2024080872A1 (en) 2022-10-12 2024-04-18 Tagworks Pharmaceuticals B.V. Strained bicyclononenes
WO2024153789A1 (en) 2023-01-20 2024-07-25 Basf Se Stabilized biopolymer composition, their manufacture and use
WO2024191293A1 (en) 2023-03-10 2024-09-19 Tagworks Pharmaceuticals B.V. Trans-cyclooctene with improved t-linker
WO2025021929A1 (en) 2023-07-27 2025-01-30 Veraxa Biotech Gmbh Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same
WO2025056807A1 (en) 2023-09-15 2025-03-20 Basf Se Stabilized biopolymer composition, their manufacture and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
EP1440973A3 (de) * 1995-11-17 2004-10-20 Gesellschaft für biotechnologische Forschung mbH (GBF) Epothilonderivate, Herstellung und Mittel

Also Published As

Publication number Publication date
IL135590A0 (en) 2001-05-20
WO1999028324A1 (en) 1999-06-10
HUP0100582A3 (en) 2003-03-28
EP1042327B1 (de) 2003-09-17
AU1540899A (en) 1999-06-16
DE69818304D1 (de) 2003-10-23
HUP0100582A2 (hu) 2001-09-28
ES2207015T3 (es) 2004-05-16
JP2001525324A (ja) 2001-12-11
KR100574454B1 (ko) 2006-04-27
KR20010031976A (ko) 2001-04-16
JP4434484B2 (ja) 2010-03-17
TWI221469B (en) 2004-10-01
IL135590A (en) 2003-09-17
EP1042327A4 (de) 2002-07-17
HK1028401A1 (en) 2001-02-16
AU738576B2 (en) 2001-09-20
CA2311929A1 (en) 1999-06-10
EP1042327A1 (de) 2000-10-11
DE69818304T2 (de) 2004-07-01

Similar Documents

Publication Publication Date Title
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69627613D1 (de) Verfahren zur Rückgewinnung von Substraten
DE69911195D1 (de) Verfahren zur direktoxidation von olefinen zu olefinoxiden
DE59809789D1 (de) Verfahren zur Herstellung von Propen
DE69807157D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE69710472D1 (de) Verfahren zur direkten oxidation von olefinen zu olefinoxiden
ATE237008T1 (de) Verfahren zur elektrolytischen herstellung von metallen
DE59803117D1 (de) Verfahren zur Hydrolyse von Alkylmonohalogeniden
DE59907520D1 (de) Verfahren zur kontinuierlichen Gewinnung von (Meth)acrylsäure
DE69608083D1 (de) Verfahren zur Produktion von Polycarbonat
DE69802534D1 (de) Verfahren zur herstellung von fluorkohlenwasserstoffen
DE69605902D1 (de) Verfahren zur stabilisierung von schlamm
DE69808037D1 (de) Verfahren zur herstellung von hydroperoxiden
DE59700957D1 (de) Verfahren zur Herstellung von Propen
DE69621156D1 (de) Verfahren zur Hydrierung von Nitrilen
ATE187957T1 (de) Verfahren zur hydrierung von iminen
DE59803517D1 (de) Einstufiges verfahren zur herstellung von glykolmonoethern aus olefinen
DE69633579D1 (de) Verfahren zur Rückgewinnung von Quecksilber
DE59607103D1 (de) Verfahren zur gewinnung von 2-hydroxy-4-methylthiobuttersäure (mha)
DE69826869D1 (de) Verfahren zur herstellung von druckempfindlichen klebstoffen
DE69806074D1 (de) Verfahren zur Rückgewinnung von Acrylsäure
DE69403571D1 (de) Verfahren zur Herstellung von Acrylamid
DE59500390D1 (de) Verfahren zur Förderung von Erdöl
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE59509677D1 (de) Verfahren zur enzymatischen Spaltung von 2-Amino-4-methylphosphinobutansäureamid-Derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042327

Country of ref document: EP